Background: Pulmonary autograft dilatation after Ross operation often necessitates reoperation. To understand autograft remodeling, a biomechanical understanding of human autografts after exposure to systemic pressure is required. We previously developed an ex vivo human pulmonary autograft finite element (FE) model to predict wall stress after exposure to systemic pressure. However, autograft material properties vary significantly among individuals. Our study aim was to quantify range of wall stress changes in a human autograft after Ross operation prior to remodeling based upon normal variation in human autograft mechanical properties.

Methods: A normal human autograft FE model was loaded to pulmonary and systemic arterial pressures. Stress-strain data of normal human autografts (n=24) were incorporated into an Ogden hyper-elastic model to describe autograft mechanical behavior. Autograft wall stresses at pulmonary vs. systemic pressures were examined. Autograft volume-based stress analysis was performed, based on percentage of autograft element volume exceeding 1 standard deviation (SD) above group mean stress at systemic systole.

Results: Mean first principal wall stresses (FPS) at systole of systemic versus pulmonary pressures were 129.29±17.47kPa versus 24.42±3.85kPa (p<0.001) at the annulus, 187.53±20.06kPa versus 35.98±2.15kPa at sinuses (p<0.001), and 268.68±23.40kPa versus 50.15±5.90kPa (p<0.001) at sinotubuluar junction (STJ). The percentage of autograft element volume that exceeded one SD above the group mean was 14.3±5.6% for FPS and 12.6±10.1% for second principal stresses.

Conclusion: We quantified normal human autograft biomechanical responses to systemic pressure based on patient-specific material properties. Regions of peak stresses were observed in autograft sinuses and STJ regions, which corresponded clinically to locations of autograft dilation. Our results provide valuable information on predicting variations in patient-specific ex vivo FE models when population-based material properties are used in settings where patient-specific properties are unknown.

How to cite: Wisneski, A. D., Wang, Z., Xuan, Y., Guccione, J. M., Ge, L., & Tseng, E. E. (2019). Range of Pulmonary Autograft Responses to Systemic Pressure Immediately After Ross Procedure. The Journal of heart valve disease, 28(1), 22–31.

Heart valve disease (HVD) can be significantly influenced by systemic autoimmune diseases, which may exacerbate or modify the progression of valve pathologies. This article reviews the interplay between systemic autoimmune diseases and heart valve disease, including mechanisms, diagnostic challenges, and therapeutic approaches. We discuss the impact of autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, and scleroderma on heart valve function, and highlight recent advances in understanding and managing these complex interactions.

MicroRNAs (miRNAs) are small non-coding RNAs that play critical roles in the regulation of gene expression. In the context of heart valve development and disease, miRNAs have emerged as important regulators of cellular processes, including differentiation, proliferation, and apoptosis. This review explores the roles of various miRNAs in heart valve development and pathology, examining their mechanisms of action, potential as diagnostic biomarkers, and therapeutic targets. We summarize recent findings and discuss future directions for research in this evolving field.

Obesity has emerged as a significant risk factor for cardiovascular diseases, including heart valve diseases (HVD). This review explores the impact of obesity on the progression of heart valve diseases, including mechanisms linking obesity with valve pathology, clinical implications, and management strategies. We discuss how obesity influences the development and progression of various types of heart valve diseases, including aortic stenosis, mitral regurgitation, and tricuspid valve disorders. The review also highlights current research findings and future directions for managing obesity-related heart valve disease.

Atrial fibrillation (AF) and heart valve disease (HVD) frequently co-occur, creating complex clinical scenarios that challenge diagnosis and management. This review explores the interplay between AF and HVD, examining their pathophysiological connections, diagnostic approaches, and treatment strategies. We discuss how the presence of one condition can exacerbate the other and highlight current research findings on managing these dual diagnoses.

Extracellular matrix (ECM) remodeling is a fundamental process in the pathogenesis of heart valve diseases. This review examines the role of ECM remodeling in valve disease progression, highlighting the molecular mechanisms, key regulatory factors, and clinical implications. We discuss how alterations in ECM composition and structure contribute to the development and progression of various heart valve diseases, including aortic stenosis, mitral regurgitation, and tricuspid valve disorders. The review also explores potential therapeutic strategies targeting ECM remodeling to mitigate valve disease progression.

Radiation therapy, commonly used in the treatment of various malignancies, has been associated with long-term cardiovascular complications, including heart valve dysfunction. This longitudinal study investigates the effects of radiation therapy on heart valve function over an extended period. We analyze changes in valve function, mechanisms of radiation-induced damage, and implications for patient management. The findings underscore the importance of monitoring heart valve health in patients with a history of radiation therapy and provide insights into potential preventive and therapeutic strategies.

Wearable technology is transforming the field of cardiovascular health by providing real-time monitoring and data collection for various conditions, including heart valve disease. This research article explores the application of wearable devices in tracking the progression of heart valve disease, evaluating their effectiveness, and discussing their potential to improve patient outcomes. We review current technologies, their integration into clinical practice, and future directions for research in wearable health monitoring.

Reoperative valve surgery is a challenging procedure with varied outcomes based on numerous factors. This study examines the outcomes of reoperative valve surgery, identifies key risk factors and predictors of adverse events, and provides insights into improving patient outcomes. By analyzing clinical data from multiple centers, we aim to enhance understanding of reoperative valve surgery and inform strategies to optimize patient care.

Heart valve disease is increasingly recognized as a condition with significant immunological underpinnings. This research article explores the role of inflammation and fibrosis in the pathogenesis of heart valve disease. We review the mechanisms by which immune responses contribute to valve dysfunction, the progression from inflammation to fibrosis, and the potential for targeted immunological therapies. Insights from recent studies and clinical trials are discussed to highlight the impact of these mechanisms on disease management and patient outcomes.

Transcatheter mitral valve repair (TMVR) has revolutionized the treatment of mitral valve disease, offering a less invasive alternative to surgical repair. This article reviews current trends in TMVR, including recent advancements in technology and procedural techniques. It also explores future directions in the field, emphasizing emerging technologies and potential areas for research. By synthesizing recent studies and clinical trials, this review aims to provide a comprehensive overview of TMVR's progress and future prospects.